ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.
The pharma royalty funding market hit a record $10 billion in 2025. A single AI experiment that improved a cancer drug in ...
Rolls-Royce is introducing its Coachbuild Collection program, one that will give clients infinite opportunities for a custom Rolls-Royce, even more so than before. Its first launch has been revealed ...
Anthropic released nine new Claude connectors on April 28, plugging the assistant directly into the software professional creatives already use — Adobe Creative Cloud, Blender, Ableton Live, Autodesk ...
Researchers have developed a new artificial intelligence (AI) model that can more accurately predict how proteins interact ...
SYNTHBODY(TM) introduces a new class of "smart drugs": protein therapeutics with built-in, multi-layered logic gates that actively change how they behave based on what they encounter in the body, a ...
Research into human genomic diversity has a number of applications in biomedicine, evolution, and history. However, many ...
Outspoken Marvel star Evangeline Lilly has slammed Disney for its recent round of layoffs, which reportedly left 1,000 staff ...
This week may have been all about football in Southwestern Pennsylvania, but the first round of the NHL Playoffs have also ...
SOMERVILLE, MA, UNITED STATES, April 27, 2026 /EINPresswire.com/ -- Why does a single fluorine atom often influence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results